Table 5 Results of multiple regression analyses with clinical measurements as dependent variables and oxidative stress toxicity (OSTOX) and antioxidant (ANTIOX) biomarkers as explanatory variables.
Regression | Explanatory variables | β | t | p | F model | df | p | R2 |
|---|---|---|---|---|---|---|---|---|
#1. Depression HAMD | Model | 23.16 | 5/150 | <0.001 | 0.441 | |||
Body temperature | 0.390 | 5.12 | <0.001 | |||||
OSTOX | 2.37 | 3.70 | <0.001 | |||||
SpO2 | −0.195 | −2.49 | 0.014 | |||||
Education | −0.161 | −2.59 | 0.011 | |||||
Age | −0.137 | −2.21 | 0.028 | |||||
#2. Somatic HAMD | Model | 30.59 | 4/151 | <0.001 | 0.448 | |||
SpO2 | −0.427 | −5.48 | <0.001 | |||||
Body temperature | 0.238 | 3.14 | 0.002 | |||||
Astra + Pfizer | 0.158 | 2.57 | 0.011 | |||||
NO | 0.149 | 2.41 | 0.017 | |||||
#3. Depression HAMA | Model | 26.14 | 3/152 | <0.001 | 0.340 | |||
SpO2 | −0.511 | −7.64 | <0.001 | |||||
Female sex | 0.223 | −3.38 | <0.001 | |||||
Astra + Pfizer | 0.133 | 1.99 | 0.048 | |||||
#4. Somatic HAMA | Model | 41.14 | 5/150 | <0.001 | 0.578 | |||
SpO2 | −0.533 | −7.78 | <0.001 | |||||
Body temperature | 0.241 | 3.61 | <0.001 | |||||
Astra + Pfizer | −0.134 | 2.50 | 0.014 | |||||
NO | 0.123 | 2.27 | 0.025 | |||||
Femal sex | −0.114 | −2.13 | 0.035 | |||||
#5. Somatic FF | Model | 53.60 | 4/151 | <0.001 | 0.587 | |||
SpO2 | −0.457 | −6.84 | <0.001 | |||||
Body temperature | 0.322 | 4.95 | <0.001 | |||||
NO | 0.151 | 2.80 | 0.006 | |||||
MDA | 0.132 | 2.49 | 0.014 | |||||
#6. Neuropsychiatric symptoms score | Model | 59.77 | 4/151 | <0.001 | 0.613 | |||
SpO2 | −0.531 | −8.02 | <0.001 | |||||
Body temperature | 0.246 | 3.90 | <0.001 | |||||
OSTOX/ANTIOX | 0.151 | 2.73 | 0.007 | |||||
Female sex | 0.111 | 2.19 | 0.030 | |||||
#7. OSTOX/ANTIOX | Model | 30.26 | 1/154 | <0.001 | 0.164 | |||
SpO2 | −0.405 | −5.50 | <0.001 | |||||
#9. CRP | Model | 46.14 | 2/153 | <0.001 | 0.376 | |||
Body Temperature | 0.568 | 8.90 | <0.001 | |||||
Male sex | 0.245 | 3.83 | <0.001 | |||||